Previous studies showed that Fms-like tyrosine kinase-3 ligand (flt3-L), a hematopoietic four helical bundle cytokine, can induce remarkable growth inhibition of prostate tumor cells that grow at an ectopic site. The gene discussed is FLT3LG; the disease is prostate neoplasm.